Investors Are Waking Up To Kintara Therapeutics Inc (NASDAQ: KTRA) After Losing -95.52% Over The Past 12 Months

Kintara Therapeutics Inc (NASDAQ:KTRA) currently has a daily average trading volume of 9.21M but it saw 2202570 shares traded in last market. With a market cap of 10.29M USD, the company’s current market price of $0.19 came falling about -4.91 while comparing to the previous closing price of $0.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.00 and as low as $0.08. In the recent trading on the day, stock has struck highest price mark of $0.1749 while lowest mark touched by it was $0.1999.

Taking a look at 20-day trading activity of Kintara Therapeutics Inc (KTRA) gives us an average price of $0.1988, while its current price level is -96.28% below from 52-week high level whereas it is 129.51% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2375 while that of 200 days or SMA-200 reads an average of $0.1861. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.28% during that period while stretching the period over a month that decreases to 11.49%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 40.70 which implies that the stock is in neutral territory.

Over the week, KTRA’s stock price is moving -16.19% down while it is -16.93% when we observe its performance for the past one month. Year-to-date it is 9.61% up and over the past year, the stock is showing a downside performance of -95.52%.

Currently, Kintara Therapeutics Inc’s total number of outstanding shares is 55.37M with 0.12% of that held by the insiders while 1.48% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -160.62% and return on equity (ROE) at -192.23%. Stock’s beta reads 0.81. Its return on asset (ROA) is -131.55% on average.